Contact
Please use this form to send email to PR contact of this press release:
Cellceutix Phase 2 Trial of Prurisol for Mild to Moderate Psoriasis Meets Primary Endpoint
TO:
Please use this form to send email to PR contact of this press release:
Cellceutix Phase 2 Trial of Prurisol for Mild to Moderate Psoriasis Meets Primary Endpoint
TO: